Following the revelation of research fraud at a Pfizer subcontractor, 16 physicians and researchers are now calling for a halt to coronavacination in Sweden.
Extensive Research Fraud
On Nov. 2, the British Medical Journal (BMJ) revealed that a Pfizer subcontractor likely committed extensive research fraud during the fall 2020 Phase III trial of Pfizer’s Cov vaccine.
The revelation, which received little media attention, is based on information provided by whistleblower Brook Jackson, the September 2020 Texas regional director of Ventavia Research Group, the research organization involved in Pfizer’s vaccine trials.
Jackson’s testimony shows that the company falsified data, blinded patients, hired inadequately trained vaccinators and was slow to follow up on adverse events reported in the Phase III trial. Quality control staff were overwhelmed by the number of problems discovered.
After repeatedly alerting Ventavia to the deficiencies, Brook Jackson filed a complaint with the U.S. Food and Drug Administration (FDA) via email on September 25, 2020. Ventavia dismissed it the same day. To support her criticism, Jackson submitted dozens of internal company documents, photos, audio recordings and emails to the BMJ. The BMJ backed up her testimony with statements from many former Ventavia employees.
The British Medical Journal article also indicates that the FDA never reviewed the company where Ms. Jackson worked. The article describes the FDA as having too few resources to review clinical trials. From 2000 to 2005, only about 1% of all studies were reviewed, and since then the number of reviews has declined. In August 2021, the FDA published a review of the number of reviews of Pfizer’s vaccine trials. In total, 9 of 153 study sites were reviewed, representing 6% of study sites.
The 16 Swedish physicians and researchers who signed the new petition write that they “find the BMJ’s report extremely concerning.”
“This undermines confidence in Pfizer, the company responsible for testing the vaccine, and in the safety of the vaccine currently being used in Sweden, including hundreds of thousands of children,” the doctors write.
They also note that the number of reported suspected adverse reactions to the Covid vaccine is also “gigantic.” For example, 83,744 suspected adverse reactions were reported in Sweden in the 10 months following vaccination, which is more than 10 times the number of all adverse reactions reported for all drugs and vaccines in previous years, totaling about 25,000 substances.
“About 20 studies have shown that the efficacy of the vaccine is very weak. One of these studies, the Swedish one, showed that the vaccine had a good effect for about two months, that AstraZeneca’s vaccine had no effect against the delta variant after four months, and that the same was true for Pfizer’s vaccine after seven months,” the doctors write.
“The strong suspicion that parts of the clinical trial for Pfizer’s vaccine were not conducted in a scientifically acceptable manner and that the results of the trial cannot be considered reliable, combined with the large number of reported suspected adverse events following vaccination, many of which are serious, is of great concern to us as physicians, scientists and immunologists.
This is not least true for children, who are at extremely low risk of severe disease from Covid-19 but at risk of severe adverse events. The fact that the vaccine’s efficacy has declined significantly after only a few months and is weak against the delta variant of the virus contributes to our conclusion that covid vaccination should be paused in Sweden until a benefit-risk calculation has been performed for all age groups. Our position stems from the revelations in the BMJ and what we now know about the risks to patients.”
The call was Signed by these Individuals:
Nils Littorin, MD; PhD in clinical microbiology.
Magnus Burling, MD, a specialist in general medicine,
Sture Blomberg, specialist in anesthesiology and intensive care medicine; associate professor
Ragnar Hultborn, specialist in oncology; professor emeritus
Lilian Weiss, specialist in general surgery; associate professor
Ann-Cathrin Engwall, immunologist and virologist; doctorate in molecular cell biology with an immunology focus
Sebastian Rushworth, Intern
Maria Papadopoulou, ophthalmologist
Carina Ljungfelt, specialist in general medicine
Christina Malm, specialist in general medicine,
Bo Jonsson, specialist in general psychiatry; MD
Anette Stahel, MSc in Biomedical Sciences,
Nina Yderberg, specialist in child and adolescent psychiatry
Dinu Dusceac, specialist in cardiology; PhD
Margareta Andersson, Specialist in General Medicine
Hanna Åsberg, Specialist in General Medicine